21 CFR 524.155

§ 524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 524.155, § 524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87571
Permanent ID: ys:prov:87571@1
SHA-256: 7cda2bbfec403cc2df1a0eb12344667e13332ef4e511c4d60fa9e9650e550e59

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each gram of ointment contains 400 units of bacitracin zinc, 5 milligrams (mg) of neomycin sulfate (equivalent to 3.5 mg of neomycin sulfate), 10,000 units of polymyxin B sulfate, and10 mg of hydrocortisone. (b) Sponsors. See Nos. 000061 and 043264 in § 510.600(c) of this chapter. (c) Conditions of use in dogs and cats—(1) Amount. Apply a thin film over the cornea three or four times daily. (2) Indications for use. For treating acute or chronic conjunctivitis caused by susceptible organisms. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.